FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to gastroenterology. For differential diagnosis of variants of functional dyspepsia, the initial concentration of motilin and the concentration of motilin are measured after a drinking test with the use of non-carbonated drinking water at room temperature until a feeling of full saturation. With an increase in the concentration of motilin after taking a liquid by 5% or more compared to the baseline, epigastric pain syndrome is diagnosed, and with a decrease of 5% or more compared to the baseline, postprandial distress syndrome is diagnosed.
EFFECT: invention enables differential diagnosis of functional dyspepsia variants and prescribing pathogenetically substantiated treatment.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSING DISORDERS OF ACCOMMODATION OF THE STOMACH | 2021 |
|
RU2761722C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF EPIGASTRAL PAIN SYNDROME | 2001 |
|
RU2226070C2 |
| MEDICATION FOR FUNCTIONAL GASTROINTESTINAL DISORDERS | 2020 |
|
RU2744125C1 |
| VISCERAL HYPERSENSITIVITY ASSESSMENT METHOD | 2020 |
|
RU2725197C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF ANTRODUODENAL COORDINATION | 2004 |
|
RU2277859C2 |
| NEW [2-(DIMETHYLAMINO)-2-PHENYLBUTYL]-3,4,5-TRIMETOXYBENZOATE 4-METHYL-2H-CHROMEN-2-ON-7-ILSULPHATE COMPOUND AND APPLICATION THEREOF | 2020 |
|
RU2752086C1 |
| METHOD OF ESTIMATION OF THE TREATMENT AND DIAGNOSTICS EFFICIENCY OF THE CLINICAL COURSE SEVERITY OF THE GASTROINTESTINAL TRACT FUNCTIONAL DISORDERS | 2016 |
|
RU2655540C2 |
| METHOD FOR DIAGNOSING THE SEVERITY OF FUNCTIONAL DISORDERS OF THE GASTROINTESTINAL TRACT | 2017 |
|
RU2688308C2 |
| METHOD FOR DIAGNOSING CENTRAL SENSITIZATION IN FUNCTIONAL DYSPEPSIA | 2021 |
|
RU2774016C1 |
| NEW SALTS OF [2-(DIMETHYLAMINO)-2-PHENYLBUTYL]-3,4,5-TRIMETHOXYBENZOATE AND APPLICATION THEREOF | 2021 |
|
RU2777365C1 |
